The merged basins of signal transduction pathways in spatiotemporal cell biology

Journal of Cellular Physiology

Volumn 229, Issue 3, 2014, Pages 287-291

  Hou, Yingchun ^a   Hou, Yang ^b   He, Siyu ^c   Ma, Caixia ^a   Sun, Mengyao ^a   He, Huimin ^a   Gao, Ning ^a  

^a SHAANXI NORMAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HISTONE H3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELIN; TRANSCRIPTION FACTOR; VASCULOTROPIN RECEPTOR 3;

ARTICLE; CELL COMMUNICATION; COLORECTAL CARCINOMA; CYTOLOGY; DEVELOPMENTAL BIOLOGY; DEVELOPMENTAL STAGE; EMBRYO DEVELOPMENT; FEEDBACK SYSTEM; GENE CLUSTER; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENETIC REGULATION; HUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WNT SIGNALING PATHWAY;

ANIMALS; CELL BIOLOGY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 84888070829     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24449     Document Type: Article

References (30)

1. Baron R, Kneissel M. 2013. WNT signaling in bone homeostasis and disease: From human mutations to treatments. Nat Med 19:179-192.
2. Dhillon AS, Hagan S, Rath O, Kolch W. 2007. MAP kinase signalling pathways in cancer. Oncogene 26:3279-3290.
3. Errede B, Ge QY. 1996. Feedback regulation of map kinase signal pathways. Philos Trans R Soc Lond B Biol Sci 351:143-149.
4. Grewal T, Enrich C. 2009. Annexins-modulators of EGF receptor signalling and trafficking. Cell Signal 21:847-858.
5. Hao N, Budnik BA, Gunawardena J, O'Shea EK. 2013. Tunable signal processing through modular control of transcription factor translocation. Science 339:460-464.
6. Hedhli N, Falcone DJ, Huang B, Cesarman-Maus G, Kraemer R, Zhai H, Tsirka SE, Santambrogio L, Hajjar KA. 2012. The annexin A2/S100A10 system in health and disease: Emerging paradigms. J Biomed Biotechnol 2012:1-13.
7. Hou Y, Yang L, Mou M, Hou Y, Zhang A, Pan N, Qiang R, Wei L, Zhang N. 2008. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells. Cancer Invest 26:809-815.
8. Hou Y, Xing R, Hou Y, Mu M, Yang Y, Ge Y. 2011. When, where, which. J Cell Physiol 226:291.
9. Hou Y, Hou Y, He S, Xing R. 2012. The novel insights into spatiotemporal cell biology and its schematic frame, triple W. J Cell Physiol 227:1787-1790.
10. Ichise T, Yoshida N, Ichise H. 2012. Ras/MAPK signaling modulates VEGFR-3 expression through Ets-mediated p300 recruitment and histone acetylation on the Vegfr3 gene in lymphatic endothelial cells. PLoS ONE 7:e51639.
11. Ishii A, Furusho M, Bansal R. 2013. Sustained activation of ERK1/2 MAPK in oligodendrocytes and schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion. J Neurosci 33:175-186.
12. Jang S, Atkins MB. 2013. Which drug, and when, for patients with BRAF-mutant melanoma? Lancet Oncol 14:e60-e69.
13. Junttila MR, Li SP, Westermarck J. 2008. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 22:954-965.
14. Li F, Chung H, Reddy SV, Lu G, Kurihara N, Zhao AZ, Roodman GD. 2005. Annexin II stimulates RANKL expression through MAPK. J Bone Miner Res 20:1161-1167.
15. Liebmann C, Böhmer FD. 2000. Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: Lessons from bradykinin signaling. Curr Med Chem 7:911-943.
16. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. 2000. Molecular cell biology, 4th edition. New York: W. H. Freeman. ISBN-10: 0-7167-3136-3. Section 20.7: Interaction and regulation of signaling pathways.
17. Logan CY, Nusse R. 2004. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781-810.
18. Maruotti N, Corrado A, Neve A, Cantatore F. 2013. Systemic effects of Wnt signaling. J Cell Physiol 228:1428-1432.
19. Matsuzaki K. 2011. Smad phosphoisoform signaling specificity: The right place at the right time. Carcinogenesis 32:1578-1588.
20. Murphy LO, Blenis J. 2006. MAPK signal specificity: The right place at the right time. Trends Biochem Sci 31:268-275.
21. Neuert G, Munsky B, Tan RZ, Teytelman L, Khammash M, van Oudenaarden A. 2013. Systematic identification of signal-activated stochastic gene regulation. Science 339:584-587.
22. Pérez-Bercoff A, Hudson CM, Conant GC. 2013. A conserved Mammalian protein interaction network. PLoS ONE 8:e52581. Epub Jan 2, 2013.
23. Reis M, Liebner S. 2013. Wnt signaling in the vasculature. Exp Cell Res 319:1317-1323.
24. Romay-Penabad Z, Montiel-Manzano MG, Shilagard T, Papalardo E, Vargas G, Deora AB, Wang M, Jacovina AT, Garcia-Latorre E, Reyes-Maldonado E, Hajjar KA, Pierangeli SS. 2009. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood 114:3074-3083.
25. Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E. 2013. The way Wnt works: Components and mechanism. Growth Factors 31:1-31.
26. Vedeler A, Hollås H, Grindheim AK, Raddum AM. 2012. Multiple roles of annexin A2 in post-transcriptional regulation of gene expression. Curr Protein Pept Sci 13:401-412.
27. Verkaar F, Cadigan KM, van Amerongen R. 2012. Celebrating 30 years of Wnt signaling. Sci Signal 5:mr2.
28. Won JK, Yang HW, Shin SY, Lee JH, Heo WD, Cho KH. 2012. The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor. J Mol Cell Biol 4:153-163.
29. Xing R, He H, He Y, Feng Y, Zhang C, Wu H, Sun M, Yu X, Liu Y, Song X, Wang X, Chen Y, Hou Y. 2013. ANXA2 remodels the microstructures of caco2 cells. Cell Mol Biol (Noisy-le-grand) 59: Suppl:OL1848-OL1854.
30. Yang SH, Sharrocks AD, Whitmarsh AJ. 2013. MAP kinase signalling cascades and transcriptional regulation. Gene 513:1-13.